LGM
Logos Global Management’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-900,000
| Closed | -$42.3M | – | 45 |
|
|
2024
Q4 | $42.3M | Buy |
900,000
+500,000
| +125% | +$23.5M | 4.95% | 4 |
|
|
2024
Q3 | $21.1M | Buy |
+400,000
| New | +$21.1M | 2.28% | 19 |
|
|
2024
Q2 | – | Sell |
-100,000
| Closed | -$7.01M | – | 56 |
|
|
2024
Q1 | $7.01M | Sell |
100,000
-1,525,000
| -94% | -$107M | 0.57% | 35 |
|
|
2023
Q4 | $136M | Buy |
1,625,000
+375,000
| +30% | +$31.3M | 12.66% | 1 |
|
|
2023
Q3 | $36.8M | Sell |
1,250,000
-400,000
| -24% | -$11.8M | 4.91% | 5 |
|
|
2023
Q2 | $53.8M | Buy |
1,650,000
+400,000
| +32% | +$13M | 7.32% | 2 |
|
|
2023
Q1 | $44M | Sell |
1,250,000
-250,000
| -17% | -$8.8M | 6.3% | 3 |
|
|
2022
Q4 | $68.7M | Sell |
1,500,000
-200,000
| -12% | -$9.16M | 8.05% | 3 |
|
|
2022
Q3 | $82.4M | Sell |
1,700,000
-50,000
| -3% | -$2.42M | 10.13% | 2 |
|
|
2022
Q2 | $68.8M | Buy |
1,750,000
+135,000
| +8% | +$5.3M | 12.61% | 1 |
|
|
2022
Q1 | $59.4M | Buy |
1,615,000
+290,000
| +22% | +$10.7M | 7.71% | 1 |
|
|
2021
Q4 | $60.4M | Buy |
1,325,000
+325,000
| +33% | +$14.8M | 6.23% | 2 |
|
|
2021
Q3 | $35.7M | Sell |
1,000,000
-400,000
| -29% | -$14.3M | 2.58% | 14 |
|
|
2021
Q2 | $27.7M | Buy |
1,400,000
+700,000
| +100% | +$13.9M | 2.33% | 17 |
|
|
2021
Q1 | $16.3M | Buy |
+700,000
| New | +$16.3M | 1.59% | 16 |
|
|
2020
Q4 | – | Sell |
-750,000
| Closed | -$16.2M | – | 60 |
|
|
2020
Q3 | $16.2M | Sell |
750,000
-50,000
| -6% | -$1.08M | 2.08% | 15 |
|
|
2020
Q2 | $18.9M | Buy |
800,000
+606,871
| +314% | +$14.3M | 3.77% | 7 |
|
|
2020
Q1 | $2.28M | Buy |
+193,129
| New | +$2.28M | 0.87% | 35 |
|